CClinicalTrials.gg
CompletedNCT03281616Updated Sep 19, 2017

Lifestyle in Turkish-Background Diabetics

An interventional study of Diet in Diabetes Mellitus, sponsored by Charite University, Berlin, Germany. Completed. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-09-19.

Sponsored by Charite University, Berlin, Germany · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

Background: Life-style interventions are indicated in patients with metabolic syndrome and/or type 2 diabetes. However, cultural differences are substantial confounders to not only compliance, but also whether or not the interventions are offered in the first place. In Germany, the large Turkish-background minority has a particularly high incidence of type 2 diabetes, but there is no recorded evidence of a life-style intervention in this patient group.

Objective: The investigators tested the body weight-reducing effect of a 30% calorie-reduced diet, adjusted to individual eating habits and preferences regarding quality and resources of food in a Turkish-background cohort.

Read the detailed description

The investigators conducted a prospective, randomized, two-arm parallel study. In both arms, patients were instructed in a 12-week diet that was reduced by in caloric content by at least 30% based on calorimetric measurements of 24 h resting energy expenditure and estimated additional expenditures by diet- and activity-induced thermogenesis. Before and after the diet, anthropometric measures and various MetS-associated blood parameters were determined.

The subjects were not instructed in an exercise program. However, the subjects were advised on the value of increased physical activity. For additional motivation, effects were tested by an activity monitor. Therefore, in one of the arms, 24 hour locomotor activity and energy expenditure were determined by means of the SenseWear® MF armband (Body Media Inc., AliphCom dba Jawbone®, Pittsburgh, PA, U.S.A.). This device detects activity contest using accelerometers and assesses daily energy expenditure. For allocation of the subjects, a computer-generated list of random numbers was used. The randomization sequence was created using SPSS 18 (SPSS, Inc., Chicago, IL, USA) statistical software and subjects were assigned to be tested or not for locomotor activity with a 1:1 allocation using random block sizes of 2, 4, and 6.

02

Conditions studied

  • Diabetes Mellitus

Browse trials for

03

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 30 - 65 years
  • BMI 30 - 40 kg/m2
  • non-Insulin dependent diabetes

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • more than 3 anti-diabetic drugs
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
110 participants (actual)

Study arms

  • Active comparator
    Diet and Physical Activity Recording

    Behavioral: Diet

  • Active comparator
    Diet and No Physical Activity Recording

    Behavioral: Diet

Interventions

  • BehavioralDiet

    Individually tailored diets; 30% caloric reduction according to daily energy requirements measured by indirect calorimetry

05

What researchers measure

Primary outcomes

  1. Body weight reduction

    Changes in body weight (kg) within 12 weeks of diet

    Time frame: 12 weeks

Secondary outcomes

  1. Blood glucose

    Changes in blood glucose (mmol/L) within 12 weeks of diet

    Time frame: 12 weeks

  2. Blood HbA1c

    Changes in blood glycated hemoglobin within 12 weeks of diet

    Time frame: 12 weeks

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03281616
Lead sponsor
Charite University, Berlin, Germany
Responsible party
Michael Boschmann (Physician, Charite University, Berlin, Germany) — Principal investigator
First posted
Sep 13, 2017
Start date
Jun 1, 2014
Primary completion
Jun 30, 2015
Completion
Sep 30, 2015
Last update
Sep 19, 2017

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion